GR82048B - - Google Patents
Info
- Publication number
- GR82048B GR82048B GR74846A GR840174846A GR82048B GR 82048 B GR82048 B GR 82048B GR 74846 A GR74846 A GR 74846A GR 840174846 A GR840174846 A GR 840174846A GR 82048 B GR82048 B GR 82048B
- Authority
- GR
- Greece
- Prior art keywords
- discoloured
- carbodiimides
- pyridines
- pure
- compounds
- Prior art date
Links
- 239000003377 acid catalyst Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001718 carbodiimides Chemical class 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 steroid ester Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Amplifiers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8303031A SE8303031D0 (sv) | 1983-05-30 | 1983-05-30 | Improved steroid esters preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR82048B true GR82048B (el) | 1984-12-12 |
Family
ID=20351375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR74846A GR82048B (el) | 1983-05-30 | 1984-05-28 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4537722A (el) |
| EP (1) | EP0127829B1 (el) |
| JP (1) | JPS6041696A (el) |
| AT (1) | ATE32603T1 (el) |
| AU (1) | AU560235B2 (el) |
| CA (1) | CA1211430A (el) |
| DE (1) | DE3469440D1 (el) |
| DK (1) | DK162100C (el) |
| ES (1) | ES8503008A1 (el) |
| FI (1) | FI80710C (el) |
| GR (1) | GR82048B (el) |
| HU (1) | HU198217B (el) |
| IE (1) | IE57425B1 (el) |
| IL (1) | IL71870A (el) |
| NZ (1) | NZ208174A (el) |
| PT (1) | PT78661B (el) |
| SE (1) | SE8303031D0 (el) |
| ZA (1) | ZA843946B (el) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776923A (en) * | 1993-01-19 | 1998-07-07 | Endorecherche, Inc. | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
| ATE322271T1 (de) * | 1993-01-19 | 2006-04-15 | Endorech Inc | Therapeutische verwendungen von dehydroepiandrosteron zur behandlung von verminderter libido und osteoporose |
| DE4433374A1 (de) * | 1994-09-20 | 1996-03-21 | Hoechst Ag | 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| US5892068A (en) * | 1998-08-25 | 1999-04-06 | Mcneil-Ppc, Inc. | Preparation of sterol and stanol-esters |
| US6087522A (en) * | 1999-10-12 | 2000-07-11 | Fan Tech Corporation | Silicone lanolin esters |
| ES2382609T3 (es) * | 2004-01-16 | 2012-06-11 | Cedarburg Pharmaceuticals, Inc. | Exemestano y sus productos intermedios y métodos de preparación de los mismos |
| JP5579074B2 (ja) * | 2008-11-10 | 2014-08-27 | 株式会社ブリヂストン | 変性天然ゴム及びその製造方法、並びにそれを用いたゴム組成物及びタイヤ |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1050883A (el) * | ||||
| DE1958954C3 (de) * | 1969-11-24 | 1978-11-30 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Veresterung von Alkoholen |
| US3678082A (en) * | 1970-07-30 | 1972-07-18 | Searle & Co | Esterification of 17-hydroxy steroids |
| GB1558472A (en) * | 1976-01-22 | 1980-01-03 | Leo Ab | 17-esters of 17- hydroxy gestogens |
| GB1565680A (en) * | 1976-12-31 | 1980-04-23 | Leo Ab | Method for the preparation of carboxylic acid esters |
-
1983
- 1983-05-30 SE SE8303031A patent/SE8303031D0/xx unknown
-
1984
- 1984-05-14 IE IE1192/84A patent/IE57425B1/en not_active IP Right Cessation
- 1984-05-16 NZ NZ208174A patent/NZ208174A/en unknown
- 1984-05-18 CA CA000454726A patent/CA1211430A/en not_active Expired
- 1984-05-18 IL IL71870A patent/IL71870A/xx not_active IP Right Cessation
- 1984-05-19 AT AT84105741T patent/ATE32603T1/de not_active IP Right Cessation
- 1984-05-19 DE DE8484105741T patent/DE3469440D1/de not_active Expired
- 1984-05-19 EP EP84105741A patent/EP0127829B1/en not_active Expired
- 1984-05-24 ZA ZA843946A patent/ZA843946B/xx unknown
- 1984-05-28 GR GR74846A patent/GR82048B/el unknown
- 1984-05-29 PT PT78661A patent/PT78661B/pt unknown
- 1984-05-29 DK DK265484A patent/DK162100C/da not_active IP Right Cessation
- 1984-05-29 ES ES532905A patent/ES8503008A1/es not_active Expired
- 1984-05-29 HU HU842072A patent/HU198217B/hu unknown
- 1984-05-29 US US06/614,991 patent/US4537722A/en not_active Expired - Lifetime
- 1984-05-30 FI FI842164A patent/FI80710C/fi not_active IP Right Cessation
- 1984-05-30 AU AU28832/84A patent/AU560235B2/en not_active Expired
- 1984-05-30 JP JP59110667A patent/JPS6041696A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6041696A (ja) | 1985-03-05 |
| AU2883284A (en) | 1984-12-06 |
| IE841192L (en) | 1984-11-30 |
| FI842164A0 (fi) | 1984-05-30 |
| ZA843946B (en) | 1984-12-24 |
| PT78661A (en) | 1984-06-01 |
| FI80710C (fi) | 1990-07-10 |
| DK265484D0 (da) | 1984-05-29 |
| EP0127829B1 (en) | 1988-02-24 |
| IL71870A (en) | 1986-10-31 |
| DK265484A (da) | 1984-12-01 |
| SE8303031D0 (sv) | 1983-05-30 |
| ATE32603T1 (de) | 1988-03-15 |
| DK162100C (da) | 1992-02-24 |
| ES532905A0 (es) | 1985-02-01 |
| DE3469440D1 (en) | 1988-03-31 |
| NZ208174A (en) | 1987-04-30 |
| US4537722A (en) | 1985-08-27 |
| HUT34222A (en) | 1985-02-28 |
| EP0127829A2 (en) | 1984-12-12 |
| DK162100B (da) | 1991-09-16 |
| FI80710B (fi) | 1990-03-30 |
| CA1211430A (en) | 1986-09-16 |
| ES8503008A1 (es) | 1985-02-01 |
| HU198217B (en) | 1989-08-28 |
| IL71870A0 (en) | 1984-09-30 |
| FI842164L (fi) | 1984-12-01 |
| AU560235B2 (en) | 1987-04-02 |
| JPH0369360B2 (el) | 1991-10-31 |
| PT78661B (en) | 1986-06-26 |
| IE57425B1 (en) | 1992-09-09 |
| EP0127829A3 (en) | 1985-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69432109D1 (de) | Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung | |
| AU571225B2 (en) | Retro-inverso analogues of the bradykinin potentiating peptide bpp 5a | |
| NZ208529A (en) | 2-pyrimidinyl-1-piperazine derivatives and pharmaceutical compositions | |
| BR8501862A (pt) | Composicao adesiva estabilizada e emprego | |
| IL77396A (en) | Pharmaceutical compositions containing bicyclic heteroarylpiperazine derivatives,certain such novel compounds and their preparation | |
| EP0192988A3 (en) | Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom | |
| GR82048B (el) | ||
| HUT61202A (en) | Process for producing pharmaceutical compositions neutralizing procoagulant activity caused by tumour cells | |
| AU692988B2 (en) | Superior thrombomodulin analogs for pharmaceutical use | |
| AU7242687A (en) | Nucleic acid and methods for the synthesis of novel DAF compositions | |
| TR200101083T2 (tr) | (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim. | |
| UA15920A (uk) | Аміди циклометілеh-1, 2-дикарбоhових кислот, які мають гіпотеhзивhу активhість | |
| EP0770137A4 (en) | IMPROVEMENTS IN PROTEIN PRODUCTION IN HOST CELLS | |
| UA42797C2 (uk) | Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання | |
| ES8505351A1 (es) | Un procedimiento para preparar nuevas aroilimidazolonas | |
| ES8602676A1 (es) | Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina. | |
| AP1579A (en) | Novel 17-Halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same. | |
| ATE46692T1 (de) | (6,11-dihydro-11-oxodibenz(b,e>oxepinyl)pentaans|uren und derivate, verfahren und zwischenprodukte zu deren herstellung und deren verwendung als arzneimittel. | |
| SU1155587A1 (en) | N,n,n-tri-tert-butyloxycarbonylarginine as semi-product for synthesis of arginine containing peptides |